Breast MRI biopsy cancellation due to lesion nonvisualization

Emily B. Ambinder, Kelly S. Myers, Lisa A. Mullen, Philip Di Carlo, Mary Philip, Roberto Fragomeni, Derek Nguyen, Eniola Oluyemi

Research output: Contribution to journalArticlepeer-review

Abstract

It is a clinical dilemma when a finding reported as suspicious on a breast MRI is not visualized at the time of a scheduled MRI-guided breast biopsy. We retrospectively reviewed all canceled MRI-guided biopsies at our institution between 6/1/2009 and 9/20/2019 and found a cancellation rate of 6.9% (72/1051). In one case, a mastectomy was performed after the canceled biopsy revealing a focus of DCIS in the same quadrant as the original finding (malignancy rate 2.1%). Our results support the current practice of 6-month follow-up MRI recommendation after a canceled MRI-guided biopsy for lesion nonvisualization.

Original languageEnglish (US)
Pages (from-to)2021-2025
Number of pages5
JournalBreast Journal
Volume26
Issue number10
DOIs
StatePublished - Oct 1 2020

Keywords

  • breast biopsy
  • breast neoplasm
  • magnetic resonance imaging

ASJC Scopus subject areas

  • Internal Medicine
  • Surgery
  • Oncology

Fingerprint

Dive into the research topics of 'Breast MRI biopsy cancellation due to lesion nonvisualization'. Together they form a unique fingerprint.

Cite this